Skip to main content

Monjuvi Prices, Coupons, Copay Cards & Patient Assistance

Monjuvi (tafasitamab) is a member of the CD19 monoclonal antibodies drug class and is commonly used for Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.

Monjuvi prices

Intravenous Powder For Injection

200 mg Monjuvi intravenous powder for injection from $1,500.12 for 1 powder for injection
Quantity Per unit Price
1 $1,500.12 $1,500.12

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Get your FREE Drugs.com Discount Card

Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.

This is a drug discount program, not an insurance plan.

Monjuvi Coupons, Copay Cards and Rebates

Monjuvi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

IncyteCARES for MONJUVI Savings Program

Eligible commercially insured patients may pay as little as $0 per prescription with a maximum savings of up to $25,000 per calendar year.

Applies to:
Monjuvi
Number of uses:
per prescription per calendar year

Form more information phone: 855-452-5234 or Visit website

Patient Assistance & Copay Programs for Monjuvi

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Monjuvi (tafasitamab-cxix) Injection; IV

More information please phone: 866-316-7263 Visit website

Provider: IncyteCARES for Monjuvi Patient Assistance Program

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or Puerto Rico
  5. Patient or doctor's office can call the program to apply. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Conditional approval for 90 days. Education and support services are available. This program also provides copay/coinsurance assistance for commercially/privately insured patients Prescribers can enroll the patient online via the IncyteCARES.com website. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Monjuvi (tafasitamab-cxix) Injection; IV

More information please phone: 855-421-6172   or 855-452-5234   Visit website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.

See also: